Author Topic: takes over a year (Jan.2020)  (Read 1158 times)

gsgs

  • Administrator
  • Full Member
  • *****
  • Posts: 223
    • View Profile
Re: takes over a year (Jan.2020)
« on: June 24, 2020, 07:12:59 am »
22.05.2020 · “This contract with AstraZeneca is a major milestone in Operation Warp
Speed’s work toward a safe, effective, widely available vaccine by 2021,” U.S. Health
Secretary Alex Azar said.

Operation Warp Speed Aims to Deliver 300M Vaccine Doses by January.

A potential coronavirus vaccine developed by French drugmaker Sanofi and Britain's
GlaxoSmithKline is expected to be approved by the first half of 2021.

Sanofi said it had capacity to produce up to 1 billion doses a year

Shionogi and the NIID aim to put the vaccine on the market in fall 2021.

Pfizer/BioNTech 2M per dec31, 200M in 2021

AS, May, total capacity sourced for one billion doses through 2020 and into 2021;

AstraZeneca (ticker: AZN) has arranged for enough capacity to supply one billion doses of the vaccine in 2020 and 2021

May 21 (Reuters) - AstraZeneca expects to be able to deliver a billion doses of a possible
COVID-19 vaccine this year and next

AstraZeneca says it has secured capacity to produce 2 billion doses

84-90% of vaccine candidates fail (have "attrition") in Phase III clinical trials[4][54]

Walter Ricciardi,WHO : there is quite a strong probability that the vaccine will work

Sanofi would be able to supply up to 360 million doses of its mRNA vaccine annually

In April, Sanofi said it had manufacturing capacity for 600 million doses for its recombinant
vaccine, with the ambition to double production by mid-2021.

Sanofi said it had capacity to produce up to 1 billion doses a year

23.06.2020 · Sanofi said it had capacity to produce up to 1 billion doses a year of its recombinant
vaccine, and that it would be able to supply up to 360 million doses of its mRNA vaccine annually.

"We believe the probability of success is high enough that we are willing to support the
manufacturing at-risk," Dr. Hatchett said.

 AstraZeneca said it reached a second agreement with the Serum Institute of India to provide
one billion doses for low and middle-income countries, including 400 million by the end of this year.

Last month, AstraZeneca agreed to provide 100 million doses to the U.K., with an initial
supply of 30 million doses per September.

Initial supplies of any successful vaccine are expected to be limited. Some drugmakers have
sought to set up manufacturing capacity in multiple countries, in case individual countries
impose export bans on any successful vaccines produced within their borders.

June 04, 2020

 Jun 16 ,  HHS says vaccine likely by January

 when a safe and effective vaccine will be developed and distributed, and on Tuesday, the
Department of Health and Human Services said that January 2021 is a likely timeframe for
when that might happen.
The projection is based on the current efforts of HHS' Operation Warp Speed, an initiative that
aims to deliver 300 million doses

 stay-at-home and other social-distancing orders have cost the country an estimated $25 billion per day,

 We cannot promise a 100% chance of success, but we've maximized the probability of success," said Mango.

Bourla made the decision to spend $1 billion on the project, so if the vaccine works, it can be
made available this autumn.

At current rates, the US economy is losing about $40 billion a week.


--------------------
STAT : 2 doses may be needed